• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌的预防:我们现在在哪里,我们将走向何方?

Prevention of Ovarian Cancer: Where are We Now and Where are We Going?

机构信息

Department of Obstetrics and Gynecology, University of Washington, NE Pacific ST, Box 356460, Seattle, WA, 98195-6460, USA.

Department of Obstetrics and Gynecology, Stanford University, Palo Alto, CA, USA.

出版信息

Curr Oncol Rep. 2024 Nov;26(11):1355-1366. doi: 10.1007/s11912-024-01587-6. Epub 2024 Aug 8.

DOI:10.1007/s11912-024-01587-6
PMID:39115678
Abstract

PURPOSE OF REVIEW

To describe current and future strategies to reduce the burden of ovarian cancer through prevention.

RECENT FINDINGS

Current strategies in genetic testing are missing a substantial number of individuals at risk, representing a missed opportunity for ovarian cancer prevention. Past efforts at screening and early detection have thus far failed to improve ovarian cancer mortality, and novel techniques are needed. Surgical prevention is highly effective, but surgical menopause from oophorectomy has significant side effects. Novel surgical strategies aimed at reducing risk while minimizing these harms are currently being studied. To maximize ovarian cancer prevention, a multi-pronged approach is needed. We propose that more inclusive and accurate genetic testing to identify more individuals at risk, novel molecular screening and early detection, surgical prevention that maximizes quality of life while reducing risk, and broader adoption of targeted and opportunistic salpingectomy will together reduce the burden of ovarian cancer.

摘要

目的综述

描述通过预防来降低卵巢癌负担的当前和未来策略。

最新发现

目前的遗传检测策略遗漏了相当数量的高危人群,这是卵巢癌预防的一个错失的机会。过去的筛查和早期检测工作都未能降低卵巢癌死亡率,因此需要新的技术。手术预防非常有效,但卵巢切除术引起的手术绝经有显著的副作用。目前正在研究旨在降低风险的同时最大限度减少这些危害的新手术策略。为了最大限度地预防卵巢癌,需要采取多管齐下的方法。我们建议更具包容性和准确性的遗传检测以识别更多的高危人群,新型的分子筛查和早期检测,最大限度地提高生活质量同时降低风险的手术预防,以及更广泛地采用靶向和机会性输卵管切除术,这些策略将共同降低卵巢癌的负担。

相似文献

1
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?卵巢癌的预防:我们现在在哪里,我们将走向何方?
Curr Oncol Rep. 2024 Nov;26(11):1355-1366. doi: 10.1007/s11912-024-01587-6. Epub 2024 Aug 8.
2
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.通过早期切除输卵管和晚期卵巢切除预防卵巢癌(PROTECTOR):一项前瞻性非随机多中心试验的方案。
Int J Gynecol Cancer. 2021 Feb;31(2):286-291. doi: 10.1136/ijgc-2020-001541. Epub 2020 Sep 8.
3
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.降低卵巢癌和输卵管癌风险的干预措施:欧洲绝经与雄性激素缺乏协会立场声明
Maturitas. 2017 Jun;100:86-91. doi: 10.1016/j.maturitas.2017.03.003. Epub 2017 Mar 15.
4
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.输卵管切除术联合延迟卵巢切除术作为高风险女性降低风险的输卵管卵巢切除术替代方案,以评估预防的安全性:TUBA-WISP II 研究方案。
Int J Gynecol Cancer. 2023 Jun 5;33(6):982-987. doi: 10.1136/ijgc-2023-004377.
5
Screening and prevention of ovarian cancer.卵巢癌的筛查与预防。
Med J Aust. 2024 Mar 18;220(5):264-274. doi: 10.5694/mja2.52227. Epub 2024 Feb 14.
6
Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?输卵管切除术降低卵巢癌风险:是否是时候采用输卵管切除术单独治疗了?
J Minim Invasive Gynecol. 2021 Mar;28(3):403-408. doi: 10.1016/j.jmig.2020.09.020. Epub 2020 Oct 8.
7
Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.参与GOG-0199研究的高危女性中,在降低风险的输卵管卵巢切除术和卵巢癌筛查之间做出决策的相关因素:一项NRG肿瘤学/妇科肿瘤学组研究。
Gynecol Oncol. 2017 Apr;145(1):122-129. doi: 10.1016/j.ygyno.2017.02.008. Epub 2017 Feb 10.
8
Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy.预防性输卵管切除术联合延迟卵巢切除术以降低遗传性卵巢癌风险:一种替代策略的深入见解。
Fam Cancer. 2024 Nov;23(4):437-445. doi: 10.1007/s10689-024-00412-0. Epub 2024 Jun 21.
9
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.预防乳腺癌和卵巢癌的风险降低手术后的生活质量:系统评价和荟萃分析。
Am J Obstet Gynecol. 2023 Oct;229(4):388-409.e4. doi: 10.1016/j.ajog.2023.03.045. Epub 2023 Apr 12.
10
[Prophylactic salpingectomy or salpingo-oophorectomy as an ovarian cancer prevention?].[预防性输卵管切除术或输卵管卵巢切除术可预防卵巢癌?]
Presse Med. 2015 Mar;44(3):317-23. doi: 10.1016/j.lpm.2014.07.024. Epub 2015 Jan 8.

引用本文的文献

1
Targeting ferroptosis: a promising avenue for ovarian cancer treatment.靶向铁死亡:卵巢癌治疗的一条有前景的途径。
Front Immunol. 2025 Jun 5;16:1578723. doi: 10.3389/fimmu.2025.1578723. eCollection 2025.

本文引用的文献

1
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study.在美国女性中,结合雌激素/巴多昔芬与雌孕激素联合激素治疗的比较安全性:一项多数据库队列研究。
Menopause. 2023 Aug 1;30(8):824-830. doi: 10.1097/GME.0000000000002217. Epub 2023 Jul 11.
2
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.输卵管切除术联合延迟卵巢切除术作为高风险女性降低风险的输卵管卵巢切除术替代方案,以评估预防的安全性:TUBA-WISP II 研究方案。
Int J Gynecol Cancer. 2023 Jun 5;33(6):982-987. doi: 10.1136/ijgc-2023-004377.
3
Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review.
宫内节育器使用与子宫内膜癌、宫颈癌和卵巢癌的关系:专家综述。
Am J Obstet Gynecol. 2023 Aug;229(2):93-100. doi: 10.1016/j.ajog.2023.03.039. Epub 2023 Mar 29.
4
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.基于循环游离 DNA 甲基化测序的非侵入性多癌种检测(THUNDER):开发和独立验证研究。
Ann Oncol. 2023 May;34(5):486-495. doi: 10.1016/j.annonc.2023.02.010. Epub 2023 Feb 26.
5
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.根据遗传易感性,频繁使用阿司匹林与卵巢癌风险的关联。
JAMA Netw Open. 2023 Feb 1;6(2):e230666. doi: 10.1001/jamanetworkopen.2023.0666.
6
Uterine lavage identifies cancer mutations and increased somatic mutation burden in individuals with ovarian cancer.子宫灌洗可识别出患有卵巢癌个体的癌症突变和体细胞突变负担增加。
Cancer Res Commun. 2022 Oct;2(10):1282-1292. doi: 10.1158/2767-9764.crc-22-0314. Epub 2022 Oct 27.
7
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.遗传性乳腺癌-卵巢癌综合征中癌症的风险降低与筛查:ESMO临床实践指南
Ann Oncol. 2023 Jan;34(1):33-47. doi: 10.1016/j.annonc.2022.10.004. Epub 2022 Oct 25.
8
Concordance Between Genomic Alterations Detected by Tumor and Germline Sequencing: Results from a Tertiary Care Academic Center Molecular Tumor Board.肿瘤和胚系测序检测到的基因组改变的一致性:来自三级护理学术中心分子肿瘤委员会的结果。
Oncologist. 2023 Jan 18;28(1):33-39. doi: 10.1093/oncolo/oyac164.
9
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia.频繁使用阿司匹林与卵巢癌风险关联的修正:基于两个卵巢癌协作组个体水平数据的荟萃分析。
J Clin Oncol. 2022 Dec 20;40(36):4207-4217. doi: 10.1200/JCO.21.01900. Epub 2022 Jul 22.
10
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.风险降低型输卵管卵巢切除术(RRSO)后腹膜癌发生风险:系统评价和个体患者数据分析荟萃分析。
J Clin Oncol. 2022 Jun 10;40(17):1879-1891. doi: 10.1200/JCO.21.02016. Epub 2022 Mar 18.